ChromoGenics AB (publ): Bulletin from the Extraordinary General Meeting on 5 April 2024
ChromoGenics AB (publ) (the "Company") has today, on 5 April 2024, held an Extraordinary General Meeting. The Extraordinary General Meeting resolved to approve the Board of Directors' resolutions on directed issues of shares and there with related proposals. The notice to the Extraordinary General Meeting and the complete proposals are available on the Company's website, www.chromogenics.com. Directed share issues and there with related resolutions The Extraordinary General Meeting resolved, in accordance with the Board of Directors' proposal, to approve the Board of Directors'